Therapeutic interventions for the systemic treatment of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): An integrative review
DOI:
https://doi.org/10.33448/rsd-v12i11.43488Keywords:
Stevens-Johnson syndrome; Toxic epidermal necrolise; Systemic treatment.Abstract
The present article aims to evaluate by means of an integrative review the possible therapeutic interventions used for the systemic treatment of Stevens-Johnson Syndrome (SJS), such as toxic epidermal necrolise, or pathologies that are rare and serious. Within this aspect, it is known that systemic treatment is necessary, or which includes the use of medications such as corticosteroids, immunoglobulins and cyclosporine, possibly presenting an article or objective of addressing the characteristics of SJS and TEN, as the systemic treatment options available, The benefits and challenges of each treatment and its implications for the health of two patients. The study presents data and evidence regarding the two treatments currently available, validating the time of intervention and its respective effectiveness. Thus, articles are collected in the databases PUBMED, LILACS and SCIELO, as the forums published in the period from January 2012 to August 2023, in portuguese, english and spanish languages. Subsequently, a careful analysis of the pre-selected material was carried out, with the aim of gathering the most complete and relevant information on the subject matter of the article. This review concludes that despite the infinite number of possibilities, the use of biological TNF-alpha inhibitors and systemic corticosteroids is the most effective.
References
Allen, H. S., & Koch, S. L. (1942). The treatment of patients with severe burns. Surgery, Gynecology & Obstetrics, 79, 914.
Almeida, R. G., Deutsch, G., & Nogueira, T. A. (2021). Avaliação Dos Curativos Padronizados em um Hospital: Importância Para Dispensação e Manejo em Feridas. InterSciencePlace, 16(4).
Borchers, A. T., et al. (2008). Stevens–Johnson syndrome and toxic epidermal necrolysis. Autoimmunity Reviews, 7(8), 598-605.
Bulisani, A. C., Sanches, G., Guimarães, H., Lopes, R., Vendrame, L., & Lopes, A. (2006). Síndrome de Stevens-Johnson e necrólise epidérmica tóxica em medicina intensiva. Revista Brasileira de Terapia Intensiva, 18, 292-297.
Chang, H. C., Wang, T. J., Lin, M. H., & Chen, T. J. (2022). A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Biomedicines, 10(9), 2105. 10.3390/biomedicines10092105.
Coelho, A. B., Romanielo, A. R., Brito, A. G. B. P., Freitas, P. O., & Dantas, B. M. F. (2021). Os impactos do iam para o sistema único de saúde e para o Brasil The impacts of iam for the unique health system and for Brazil. Brazilian Journal of Health Review, 4(4), 15091-15102.
Coelho, I. D. (2013). Síndrome De Stevens-Johnson E Necrólise Epidérmica Tóxica (Doctoral dissertation, Universidade De Coimbra).
Comparin, C., Hans-Filho, G., Takita, L. C., Costa, N. C. W., Nascimento, R. A. F., & Nanni, L. C. (2012). Treatment of Toxic Epidermal Necrolysis with Intravenous Immunoglobulin: a series of three cases. An Bras Dermatol, 87(3), 477-481.
Dalmedico, M. M., et al. (2021). Efetividade da terapia larval na cicatrização de feridas complexas: overview de revisões sistemáticas. Rev Gestão e Saúde, 23(1), 146-158.
Ellender, R. P., et al. (2014). Clinical considerations for epidermal necrolysis. Ochsner Journal, 14(3), 413-417.
Emerick, M. F. B., et al. (2014). Síndrome de Stevens-Johnson e necrólise epidérmica tóxica em um hospital do Distrito Federal. Revista Brasileira de Enfermagem, 67, 898-904.
Estrella-Alonso, A., et al. (2017). Necrolisis epidérmica tóxica: un paradigma de enfermedad crítica. Revista Brasileira de Terapia Intensiva, 29, 499-508.
Houschyar, K. S., et al. (2021). Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. J Wound Care, 30(12), 1012-1019. 10.12968/jowc.2021.30.12.1012.
Jacobsen, A., et al. (2022). Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. Cochrane Database Syst Rev, 3(3), CD013130. 10.1002/14651858.CD013130.pub2.
Levy, A. F., Karnikowski, M. de R., & Campos, L. C. E. (2014). Síndrome de Stevens-Johnson e Necrólise Epidérmica Tóxica. Acta Méd Port, 35(7).
Mahar, P. D., et al. (2014). Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre. Burns, 40(8), 1743-1747.
Martínez-Cabriales, S., Gómez-Flores, M., & Ocampo-Candiani, J. (2015). Actualidades en farmacodermias severas: síndrome de Stevens-Johnson (SSJ) y necrólisis epidérmica tóxica (NET). Gac Med Mex, 151(6), 777-787.
Meira Júnior, J. D., et al. (2015). Necrólise epidérmica tóxica/síndrome de Stevens-Johnson: emergência em dermatologia pediátrica. Diagn. tratamento.
Ministério da Saúde (BR). Agência Nacional de Vigilância Sanitária. (2019). Farmacopeia Brasileira, (6a ed.). ANVISA.
Oliveira, A., Sanches, M., & Selores, M. (2011). O espectro clínico síndrome de Stevens-Johnson e necrólise epidérmica tóxica. Acta Médica Portuguesa, 24, 995-1002.
Pereira, A. L., et al. (2006). Revisão sistemática da literatura sobre produtos usados no tratamento de feridas.
Rocha, L. P. S. (2018). Relato de caso e revisão da literatura de síndrome de Stevens-Johnson associada a episódio de varicela. Arquivos Catarinenses de Medicina, 47(3), 226-234.
Roviello, C. F., et al. (2019). Manifestações e tratamento da necrólise epidérmica tóxica e da síndrome de Stevens Johnson. Journal Health NPEPS, 4(1), 319-329.
Santos Neto, F. C., et al. (2023). Abordagem cutânea na necrólise epidérmica tóxica. Revista brasileira de cirurgia plástica, 32, 128-134.
Santos, P., & Sylwanowicz, L. (2017). Steven-Johnson Syndrome. Journal of Education and Teaching in Emergency Medicine, 2(3).
Schleder, J. C., et al. (2021). Fotobiomodulação na síndrome de stevens-johnson: relato de caso. Rev. méd. Minas Gerais, e0032.
Serra, F. L. de O., et al. (2012). Necrólise epidérmica tóxica e síndrome de Stevens Johnson: atualização. Revista Brasileira de Queimaduras, 11(1), 26-30.
Souza, M. C. A., et al. (2018). Síndrome de stevens-johnson e necrólise epidérmica tóxica: relato de caso. Acta Biomedica Brasiliensia, 9(1), 184-190.
Thong, B. Y. (2013). Stevens-Johnson syndrome/toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pacific Allergy, 3(4), 215-223.
Tomasini, C., et al. (2014). From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia, 149(2), 243-261.
Wong, A., Malvestiti, A. A., & Hafner, M. (2016). Síndrome de Stevens-Johnson e necrólise epidérmica tóxica: revisão. Revista da Associação Médica Brasileira, 62, 468-473.
Zhang, S., Tang, S., Li, S., Pan, Y., & Ding, Y. (2020). Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review. J Dermatolog Treat, 31(1), 66-73. 10.1080/09546634.2019.1577548.
Zimmermann, S., Sekula, P., Venhoff, M., Motschall, E., Knaus, J., Schumacher, M., & Mockenhaupt, M. (2017). Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatol, 153(6), 514-522. 10.1001/jamadermatol.2016.5668.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sabryna Silveira Campos; Bruno Barreto Cintra; Renata Maria Visniewski Ximenes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
